| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.4M | +73.6% |
| SG&A Expense | $4.8M | +109.6% |
| Operating Income | -$9.8M | -101.5% |
| Net Income | -$12.2M | -150.3% |
| EPS (Basic) | -$4.73 | -150.3% |
| EPS (Diluted) | -$4.73 | -150.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +36.7% |
| Current Assets | $7.2M | +56.7% |
| Total Assets | $8.4M | +75.2% |
| Current Liabilities | $3.8M | +233.0% |
| Total Liabilities | $16.8M | +1362.0% |
| Stockholders' Equity | -$8.4M | -330.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -85.5% |
| Investing Cash Flow | -$525K | -283.8% |
| Financing Cash Flow | $9.4M | +2847.6% |